FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
FSTX
Delisted
FSTX was delisted on the 8th of March, 2023.
53 hedge funds and large institutions have $45.1M invested in F-star Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
85% less call options, than puts
Call options by funds: $272K | Put options by funds: $1.84M
Holders
53
Holding in Top 10
1
Calls
$272K
Puts
$1.84M
Top Buyers
| 1 | +$1.82M | |
| 2 | +$1.34M | |
| 3 | +$1.06M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$926K |
| 5 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$724K |
Top Sellers
| 1 | -$4.74M | |
| 2 | -$3.19M | |
| 3 | -$1.42M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.13M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$732K |